Acima Private Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$198K Hold
916
0.06% 114
2026
Q1
$168K Hold
916
0.05% 118
2025
Q4
$161K Hold
916
0.05% 117
2025
Q3
$128K Hold
916
0.04% 126
2025
Q2
$115K Hold
916
0.04% 129
2025
Q1
$125K Hold
916
0.05% 128
2024
Q4
$140K Hold
916
0.05% 128
2024
Q3
$178K Hold
916
0.06% 120
2024
Q2
$212K Hold
916
0.08% 116
2024
Q1
$198K Hold
916
0.07% 121
2023
Q4
$237K Hold
916
0.09% 119
2023
Q3
$235K Hold
916
0.1% 120
2023
Q2
$261K Hold
916
0.12% 114
2023
Q1
$255K Hold
916
0.13% 111
2022
Q4
$254K Hold
916
0.13% 114
2022
Q3
$245K Hold
916
0.13% 108
2022
Q2
$187K Hold
916
0.09% 122
2022
Q1
$193K Hold
916
0.09% 128
2021
Q4
$220K Hold
916
0.09% 125
2021
Q3
$259K Hold
916
0.12% 112
2021
Q2
$317K Hold
916
0.15% 103
2021
Q1
$256K Hold
916
0.13% 113
2020
Q4
$224K Hold
916
0.12% 113
2020
Q3
$260K Hold
916
0.16% 99
2020
Q2
$245K Hold
916
0.16% 105
2020
Q1
$290K Hold
916
0.22% 88
2019
Q4
$272K Hold
916
0.19% 112
2019
Q3
$213K Hold
916
0.16% 128
2019
Q2
$214K Hold
916
0.17% 119
2019
Q1
$217K Hold
916
0.19% 114
2018
Q4
$276K Buy
+916
New +$292K 0.27% 88

Other funds holding BIIB

Acima Private Wealth's BIIB Position: Q2 2026 in Review

Acima Private Wealth held its Biogen (BIIB) position steady in Q2 2026 at 916 shares worth $198K. The position accounts for 0.06% of the portfolio, ranked #114.

Acima Private Wealth first reported a position in BIIB in Q4 2018 and has held it in 31 quarters since. The position peaked at $317K in Q2 2021. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Acima Private Wealth held 916 shares of Biogen worth $198K as of Q2 2026.
  • Acima Private Wealth left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.06% of Acima Private Wealth's portfolio in Q2 2026, its #114 holding.
  • Acima Private Wealth first reported a position in Biogen in Q4 2018 and has held it in 31 quarters since.
  • Acima Private Wealth's Biogen position peaked at $317K in Q2 2021.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Acima Private Wealth's 13F filing for Q2 2026, filed 6 Jul 2026.